NEWARK, Del, April 10, 2024 (GLOBE NEWSWIRE) -- The global veterinary dermatology market is anticipated to be valued at US$ 8.9 billion by 2024. The market valuation is estimated to be US$ 22 billion by 2034, projected at a CAGR of 9.4%. The increasing prevalence of skin diseases in companion animals is a significant driver propelling the growth of the veterinary dermatology market. As pet ownership continues to rise globally, so does the occurrence of dermatological conditions in pets.
Environmental allergens, genetic predispositions, and lifestyle changes contribute to the growing incidence of skin issues in animals. Pet owners are becoming increasingly aware of the importance of proper dermatological care for their pets, leading to a higher demand for veterinary dermatology services and products.
Request A Sample Copy of This Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-19231
One of the primary threats facing the veterinary dermatology market is the emergence of antibiotic-resistant bacteria. Antibiotic resistance poses a significant challenge in treating bacterial skin infections in animals, limiting the efficacy of conventional antibacterial drugs. This threat complicates the management of dermatological conditions in pets and underscores the need for alternative treatment approaches and the development of novel antimicrobial agents to combat resistant strains effectively.
A notable trend in the veterinary dermatology market is the growing popularity of natural and organic pet skincare products. Pet owners increasingly seek safer and eco-friendly alternatives to conventional dermatological treatments, leading to a surge in demand for natural remedies and products free from harsh chemicals and additives. This trend reflects a broader shift towards holistic pet care and wellness, emphasizing promoting skin health through natural means.
Key Takeaways from the Market Study:
- Under drug class, the antibacterial drugs are registered to expand at 9.2% CAGR by 2034.
- The United Kingdom is estimated to register at a CAGR of 10.1% by 2034.
- China experiences significant growth, projected at a CAGR of 9.8% by 2034.
- Based on route of administration, the oral segment is anticipated to expand at 9% CAGR by 2034.
“The increasing awareness among pet owners about the importance of skin health in their pets is one significant driver for the veterinary dermatology market,” opines Sabyasachi Ghosh Associate Vice President at Future Market Insights (FMI).
Request Report Methodology: https://www.futuremarketinsights.com/request-report-methodology/rep-gb-19231
Competitive Landscape:
A diverse range of players, including pharmaceutical companies, specialty clinics, and diagnostic laboratories, characterizes the competitive landscape of the veterinary dermatology market.
Product innovation, pricing strategies, and geographic presence drive competition. Partnerships and collaborations among industry players also play a significant role in shaping market dynamics. Some of the key developments are:
- In October 2022, Pet King Brands, Inc. expanded its ZYMOX Enzymatic Dermatology line with three new products tailored for cats and kittens, addressing ear and skin issues.
- In January 2021, Ceva Animal Health introduced Douxo S3 Pyo skincare pads for cats and dogs, enhancing the range by offering convenient antibacterial action alongside skin hydration and protection.
Report Scope Veterinary Dermatology Market:
| Attributes | Details | ||
| Estimated Market Size in 2024 | US$ 8.9 billion | ||
| Projected Market Valuation in 2034 | US$ 22 billion | ||
| Value-based CAGR 2024 to 2034 | 9.4 % | ||
| Forecast Period | 2024 to 2034 | ||
| Historical Data Available for | 2019 to 2023 | ||
| Market Analysis | Value in US$ billion | ||
| Key Regions Covered |
| ||
| Key Market Segments Covered |
| ||
| Key Countries Profiled |
|
| |
| Key Companies Profiled |
| ||
Direct Purchase of this Report: https://www.futuremarketinsights.com/checkout/19231
Veterinary Dermatology Market - Key Segments:
By Drug Class:
- Antibacterial Drugs
- Antifungal Drugs
- Antiparasitic Drugs
- Other Drug Classes
By Indication:
- Parasitic Infections
- Allergic Infections
- Autoimmune Skin Diseases
- Skin Cancer
- Other Indications
By Route of Administration:
- Injectable
- Topical
- Oral
By Animal Type:
- Companion Animals
- Dogs
- Cats
- Horses
- Other Companion Animals
- Livestock Animals
- Bovine
- Swine
- Other Livestock Animals
By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Region:
- North America
- Latin America
- Western Europe
- Eastern Europe
- South Asia and Pacific
- East Asia
- The Middle East and Africa
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
Explore FMI’s related ongoing Coverage on Healthcare Market Insights Domain:
- Veterinary Vaccines Market Size: The net worth of the market share of veterinary vaccines is predicted to grow from US$ 11.3 Billion in 2023 to over US$ 20.82 billion by 2033. This is expected to further drive the market share of veterinary vaccines and register a CAGR of 6.2% between 2023 and 2033.
- Veterinary Biologics Market Share: The global veterinary biologics market size is estimated to reach a valuation of US$ 13,140.6 million in 2024. The market is projected to surpass US$ 24,224.3 million by 2034, registering a promising CAGR of 6.3%.
- Veterinary Wound Debridement Market Demand: The global veterinary wound debridement market was valued at US$ 714.8 Million in 2023 and is expected to reach US$ 1.5 Billion by 2033. expand at an 8.2% CAGR from 2023 to 2033.
- Veterinary Wound Cleansers Market Growth: The global veterinary wound cleansers market is expected to grow at a CAGR of 10.2%. The market value is projected to increase from US$ 185.2 Million in 2023 to US$ 488.2 Million by 2033.
- Veterinary Ultrasound Scanner Market Trends: The veterinary ultrasound scanner market is set for significant expansion, with an anticipated valuation of US$ 198.1 million by 2023. The market displays a significant trend, featuring a CAGR of 3.7%, and is poised to achieve an impressive valuation of US$ 284.8 million by 2033.
- Anti-aging Product Service and Device Market Outlook: As per the FMI’s revised market report, sales of anti-aging product services and devices accumulate a present valuation of US$ 60,764.40 million in 2024. Going by this trend, the anti-aging product service market amplifies and equates to a market worth US$ 1,01,843.40 million, with a steady CAGR of 5.30% by 2034.
- Molecular Diagnostic Market Overview: Current projections of molecular diagnostic market indicate an estimation of US$ 60,347.40 million by 2034, climbing up from US$ 39,611.00 million in 2024. After an exhaustive assessment of the market, a moderate CAGR of 4.30% is envisaged through 2034.
- Home Sleep Screening Device Market Development: In 2024, the global home sleep screening device market was valued at US$ 3,763.10 million. According to current estimations, the home sleep screening device market may garner a moderate CAGR of 4.30% from 2024 to 2034. By 2034, the market may reach a valuation of US$ 5,733.10 million by 2034.
- Non Surgical Fat Reduction Market Forecast: In the updated report by Future Market Insights, The non surgical fat reduction market is set to rise at a CAGR of 5.60% through 2034. The market value is slated to increase from US$ 1700.5 million in 2024 to US$ 2932.3 million by 2034.
- Dosimetry Market Opportunity: In a recently updated edition of the dosimetry market, FMI has assessed the market valuation to be US$ 3,144.10 million in 2024. The market is bidding for a valuation of US$ 4,882.60 million by 2034, expanding at an average 4.5% growth rate.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
